When monitoring a client receiving etanercept, which data should be collected?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Prepare for the Musculoskeletal and Medication Test with comprehensive flashcards and multiple-choice questions, complete with hints and detailed explanations. Ace your exam!

Multiple Choice

When monitoring a client receiving etanercept, which data should be collected?

Explanation:
White blood cell and platelet counts should be monitored because etanercept is a TNF inhibitor that can dampen the immune response and cause hematologic adverse effects such as neutropenia and thrombocytopenia. Regular CBC monitoring helps detect infections early and catch cytopenias before they become serious, guiding timely management. Other data like serum glucose, urinalysis for protein, or electrolytes aren’t the primary safety signals for this therapy and don’t directly address its main risks.

White blood cell and platelet counts should be monitored because etanercept is a TNF inhibitor that can dampen the immune response and cause hematologic adverse effects such as neutropenia and thrombocytopenia. Regular CBC monitoring helps detect infections early and catch cytopenias before they become serious, guiding timely management. Other data like serum glucose, urinalysis for protein, or electrolytes aren’t the primary safety signals for this therapy and don’t directly address its main risks.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy